Phase I Clinical Trial of CXR 1002 in Patients with Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2016
At a glance
- Drugs CXR 1002 (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Oct 2011 Additional location (Scotland) added as reported by United Kingdom Clinical Research Network record.
- 20 Oct 2011 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network record.
- 20 Oct 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.